by admin | Sep 23, 2026 | Case, Fitness to Practise, GPhC
The client, MD, approached me several months ago after becoming the subject of two non-clinical investigations by the General Pharmaceutical Council (GPhC). Having received a referral and undertaken considerable research into representation options, he was clear about...
by admin | Sep 23, 2026 | GDC, GMC, GOsC, GPhC, HCPC, NMC, SWE
Overview Whistleblowing remains an important route into fitness to practise investigations across UK healthcare professions. Recent data shows increases in whistleblowing disclosures across medicine, dentistry and nursing. Concerns most commonly relate to conduct,...
by admin | Aug 14, 2026 | GDC, GMC, GOsC, GPhC, HCPC, NMC, SWE
Overview The High Court refused the NMC’s application to extend an interim order, criticising aspects of the regulator’s handling of the fitness to practise case. The judgement reinforces that an interim order cannot become a substitute for progressing a...
by admin | Jun 16, 2026 | Fitness to Practise, GPhC, News
A pharmacist facing serious regulatory action in the online pharmacy sector has avoided removal from the register after the General Pharmaceutical Council’s (GPhC) Fitness to Practise Committee accepted defence submissions and imposed a suspension instead. The case...
by admin | Jun 16, 2026 | Fitness to Practise, GPhC
With representation from Kings View Chambers, a long‑running General Pharmaceutical Council (GPhC) investigation into historic governance and management concerns has concluded with no referral to a fitness to practise hearing, following detailed remediation work and...
by admin | Jun 2, 2026 | GDC, GMC, GOsC, GPhC, HCPC, NMC, SWE
Healthcare professionals who practise overseas should be aware that regulatory problems abroad do not necessarily stay abroad. The recent High Court decision in General Medical Council v Grajn [2026] EWHC 1157 (Admin) is a stark reminder that overseas disciplinary...
